Fexofenadine-induced QT prolongation: A myth or fact? [21]

British Journal of Dermatology

Volumn 142, Issue 6, 2000, Pages 1260-1261

  Dhar, Sandipan ^c   Hazra, P K ^c   Malakar, S ^a,b   Mistri, G ^a,b  

^a Advanced Medicare Research Institute   (India)

^b Duncan Gleneagles Clin/Res Ctr   (India)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; FEXOFENADINE;

AGE; AGED; ALLERGIC DISEASE; ALLERGIC RHINITIS; ANTIHYPERTENSIVE THERAPY; CARDIOTOXICITY; CASE REPORT; CHRONIC URTICARIA; DRUG INDICATION; DRUG SAFETY; DRUG WITHDRAWAL; HEART ARRHYTHMIA; HUMAN; LETTER; MALE; PRIORITY JOURNAL; QT INTERVAL; RISK FACTOR;

CONTROLLED CLINICAL TRIALS; HISTAMINE H1 ANTAGONISTS; HUMANS; LONG QT SYNDROME; TERFENADINE;

EID: 0034089249     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03576.x     Document Type: Letter

References (11)